Bristol-Myers (BMY) Reports Mixed Q3 Results; Affirms FY10 Guidance

October 26, 2010 7:31 AM

Bristol-Myers (NYSE: BMY) reports Q3 EPS of $0.59 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found